U.S. Markets open in 8 hrs 17 mins

CTI Biopharma's cancer treatment fails to meet trial goal

July 9 (Reuters) - CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage trial.

The drug, Pixuvri, was being tested in patients with aggressive B-cell Non-Hodgkin lymphoma. (Reporting by Manas Mishra in Bengaluru)